{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T21:58:31Z","timestamp":1792879111560,"version":"4.5.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Spanish Government","award":["PI14\/02070"],"award-info":[{"award-number":["PI14\/02070"]}]},{"name":"Spanish Government","award":["SAF2012-39875-C02-01"],"award-info":[{"award-number":["SAF2012-39875-C02-01"]}]},{"name":"Fundaci\u00f3n Gangoiti"},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["GRK1873"],"award-info":[{"award-number":["GRK1873"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.neuropharm.2017.08.017","type":"journal-article","created":{"date-parts":[[2017,8,12]],"date-time":"2017-08-12T11:18:41Z","timestamp":1502536721000},"page":"319-332","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":108,"special_numbering":"C","title":["GPR55: A therapeutic target for Parkinson's disease?"],"prefix":"10.1016","volume":"125","author":[{"given":"Marta","family":"Celorrio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estefan\u00eda","family":"Rojo-Bustamante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Fern\u00e1ndez-Su\u00e1rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"S\u00e1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ander","family":"Estella-Hermoso de Mendoza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christa E.","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda J.","family":"Ram\u00edrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julen","family":"Oyarz\u00e1bal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Franco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9750-1538","authenticated-orcid":false,"given":"Mar\u00eda S.","family":"Aymerich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2017.08.017_bib1","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1007\/s12035-015-9213-3","article-title":"Neuroprotective effect of JZL184 in MPP+-treated SH-SY5Y cells through CB2 receptors","volume":"53","author":"Aymerich","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2017.08.017_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.tips.2005.11.003","article-title":"In silico patent searching reveals a new cannabinoid receptor","author":"Baker","year":"2006","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2017.08.017_bib3","doi-asserted-by":"crossref","first-page":"e0167965","DOI":"10.1371\/journal.pone.0167965","article-title":"Deletion of Gpr55 results in subtle effects on energy metabolism, motor activity and thermal pain sensation","volume":"11","author":"Bjursell","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2017.08.017_bib4","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1212\/01.WNL.0000140288.48796.8E","article-title":"Cannabis for dyskinesia in Parkinson disease A randomized double-blind crossover study","volume":"63","author":"Carroll","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2017.08.017_bib5","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.bbi.2016.06.010","article-title":"Fatty acid amide hydrolase inhibition for the symptomatic relief of Parkinson's disease","volume":"57","author":"Celorrio","year":"2016","journal-title":"Brain. Behav. Immun."},{"key":"10.1016\/j.neuropharm.2017.08.017_bib6","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0011-15.2015","article-title":"Role of GPR55 during axon growth and target innervation","volume":"2","author":"Cherif","year":"2015","journal-title":"eNeuro"},{"key":"10.1016\/j.neuropharm.2017.08.017_bib7","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0223-5234(03)00012-6","article-title":"High throughput artificial membrane permeability assay for blood-brain barrier","volume":"38","author":"Di","year":"2003","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.neuropharm.2017.08.017_bib8","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/glia.20897","article-title":"Axonal plasticity elicits long-term changes in oligodendroglia and myelinated fibers","volume":"58","author":"Dr\u00f8jdahl","year":"2010","journal-title":"Glia"},{"key":"10.1016\/j.neuropharm.2017.08.017_bib9","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1038\/sj.bjp.0707337","article-title":"Cannabidiol in\u00a0vivo blunts beta-amyloid induced neuroinflammation by suppressing IL-1beta and iNOS expression","volume":"151","author":"Esposito","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.08.017_bib10","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1016\/j.neurobiolaging.2014.05.021","article-title":"Monoacylglycerol lipase inhibitor JZL184 is neuroprotective and alters glial cell phenotype in the chronic MPTP mouse model","volume":"35","author":"Fern\u00e1ndez-Su\u00e1rez","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuropharm.2017.08.017_bib11","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.brainres.2006.11.063","article-title":"Evaluation of the neuroprotective effect of cannabinoids in a rat model of Parkinson \u00e2\u20acTM s disease: importance of antioxidant and cannabinoid receptor-independent properties","volume":"1134","author":"Garc\u00eda-arencibia","year":"2006","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2017.08.017_bib12","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1177\/0269881106063264","article-title":"Studies on striatal neurotoxicity caused by the 3,4-methylenedioxymethamphetamine\/malonate combination: implications for serotonin\/dopamine interactions","volume":"20","author":"Go\u00f1i-Allo","year":"2006","journal-title":"J.\u00a0Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2017.08.017_bib13","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1124\/jpet.109.162115","article-title":"Metabotropic glutamate 7 receptor subtype modulates motor symptoms in rodent models of Parkinson's disease","volume":"332","author":"Greco","year":"2010","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2017.08.017_bib14","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1365-2818.1987.tb02837.x","article-title":"The efficiency of systematic sampling in stereology and its prediction","volume":"147","author":"Gundersen","year":"1987","journal-title":"J.\u00a0Microsc."},{"key":"10.1016\/j.neuropharm.2017.08.017_bib15","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1210\/me.2011-1197","article-title":"Minireview: recent developments in the physiology and pathology of the lysophosphatidylinositol-sensitive receptor GPR55","volume":"25","author":"Henstridge","year":"2011","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.neuropharm.2017.08.017_bib16","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1096\/fj.08-108670","article-title":"The GPR55 ligand L-alpha-lysophosphatidylinositol promotes RhoA-dependent Ca2+ signaling and NFAT activation","volume":"23","author":"Henstridge","year":"2009","journal-title":"FASEB J."},{"key":"10.1016\/j.neuropharm.2017.08.017_bib17","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1755-5949.2008.00065.x","article-title":"Cannabidiol: a promising drug for neurodegenerative disorders?","volume":"15","author":"Iuvone","year":"2009","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.neuropharm.2017.08.017_bib18","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1038\/sj.bjp.0707419","article-title":"The novel endocannabinoid receptor GPR55 is activated by atypical cannabinoids but does not mediate their vasodilator effects","volume":"152","author":"Johns","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.08.017_bib19","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1002\/glia.22560","article-title":"The G protein-coupled receptor 55 ligand l -\u03b1-Lysophosphatidylinositol exerts microglia-dependent neuroprotection after excitotoxic lesion","volume":"61","author":"Kallendrusch","year":"2013","journal-title":"Glia"},{"key":"10.1016\/j.neuropharm.2017.08.017_bib20","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/nature05506","article-title":"Endocannabinoid-mediated rescue of striatal LTD and motor deficits in Parkinson's disease models","volume":"445","author":"Kreitzer","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2017.08.017_bib21","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12950-016-0129-0","article-title":"Abnormal cannabidiol attenuates experimental colitis in mice, promotes wound healing and inhibits neutrophil recruitment","volume":"13","author":"Krohn","year":"2016","journal-title":"J.\u00a0Inflamm."},{"key":"10.1016\/j.neuropharm.2017.08.017_bib22","doi-asserted-by":"crossref","first-page":"4790","DOI":"10.1111\/bph.13250","article-title":"Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor","volume":"172","author":"Laprairie","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.08.017_bib23","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1046\/j.1365-2818.1998.00365.x","article-title":"Global spatial sampling with isotropic virtual planes: estimators of length density and total length in thick, arbitrarily orientated sections","volume":"191","author":"Larsen","year":"1998","journal-title":"J.\u00a0Microsc."},{"key":"10.1016\/j.neuropharm.2017.08.017_bib24","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.nbd.2004.11.009","article-title":"Cannabinoids provide neuroprotection against 6-hydroxydopamine toxicity in\u00a0vivo and in\u00a0vitro: relevance to Parkinson's disease","volume":"19","author":"Lastres-Becker","year":"2005","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2017.08.017_bib25","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0306-3623(90)90898-V","article-title":"Effects of probenecid on striatal dopamine depletion in acute and long-term 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mice","volume":"21","author":"Lau","year":"1990","journal-title":"Gen. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.08.017_bib26","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1073\/pnas.0711278105","article-title":"GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current","volume":"105","author":"Lauckner","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2017.08.017_bib27","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/S0022-3565(25)13256-4","article-title":"Pharmacology and stereoselectivity of structurally novel cannabinoids in mice","volume":"247","author":"Little","year":"1988","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2017.08.017_bib28","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1097\/FBP.0000000000000185","article-title":"Blockade of GPR55 in the dorsolateral striatum impairs performance of rats in a T-maze paradigm","volume":"27","author":"Marichal-Cancino","year":"2016","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.08.017_bib29","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1111\/bph.12356","article-title":"Evaluation of the insulin releasing and antihyperglycaemic activities of GPR55 lipid agonists using clonal beta-cells, isolated pancreatic islets and mice","volume":"170","author":"McKillop","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.08.017_bib30","doi-asserted-by":"crossref","DOI":"10.1007\/s00125-016-4108-z","article-title":"Metabolic effects of orally administered small-molecule agonists of GPR55 and GPR119 in multiple low-dose streptozotocin-induced diabetic and incretin-receptor-knockout mice","author":"McKillop","year":"2016","journal-title":"Diabetologia"},{"key":"10.1016\/j.neuropharm.2017.08.017_bib31","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/bph.12944","article-title":"Are cannabidiol and ??9-tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review","volume":"172","author":"McPartland","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.08.017_bib32","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/ijo.2015.209","article-title":"Deletion of G-protein-coupled receptor 55 promotes obesity by reducing physical activity","volume":"40","author":"Meadows","year":"2015","journal-title":"Int. J. Obes."},{"key":"10.1016\/j.neuropharm.2017.08.017_bib33","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13024-015-0012-0","article-title":"Promising cannabinoid-based therapies for Parkinson's disease: motor symptoms to neuroprotection","volume":"10","author":"More","year":"2015","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neuropharm.2017.08.017_bib34","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.bmcl.2008.11.075","article-title":"Potent and selective adenosine A2A receptor antagonists: 1,2,4-Triazolo[1,5-c]pyrimidines","volume":"19","author":"Neustadt","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.neuropharm.2017.08.017_bib35","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1124\/mol.108.049551","article-title":"Discovery, characterization, and antiparkinsonian effect of novel positive allosteric modulators of metabotropic glutamate receptor 4","volume":"74","author":"Niswender","year":"2008","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.08.017_bib36","series-title":"Identification of GPR55 as a Lysophosphatidylinositol Receptor","author":"Oka","year":"2007"},{"key":"10.1016\/j.neuropharm.2017.08.017_bib37","series-title":"The Mouse Brain in Sterotaxic Coordinates","author":"Paxinos","year":"2001"},{"key":"10.1016\/j.neuropharm.2017.08.017_bib38","doi-asserted-by":"crossref","DOI":"10.1111\/j.1747-0285.2006.00370.x","article-title":"GPR55 as a new cannabinoid receptor: still a long way to prove it","author":"Petitet","year":"2006","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.neuropharm.2017.08.017_bib39","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S0306-4522(01)00295-0","article-title":"Mouse model of Parkinsonism: a comparison between subacute MPTP and chronic MPTP\/probenecid treatment","volume":"106","author":"Petroske","year":"2001","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2017.08.017_bib40","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1016\/j.febslet.2009.05.028","article-title":"Differential changes in GPR55 during microglial cell activation","volume":"583","author":"Pietr","year":"2009","journal-title":"FEBS Lett."},{"key":"10.1016\/j.neuropharm.2017.08.017_bib41","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1111\/j.1460-9568.2009.06764.x","article-title":"WIN55,212-2, a cannabinoid receptor agonist, protects against nigrostriatal cell loss in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease","volume":"29","author":"Price","year":"2009","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2017.08.017_bib42","doi-asserted-by":"crossref","first-page":"8967","DOI":"10.1021\/acs.jmedchem.6b00908","article-title":"Design, synthesis, and biological evaluation of first-in-class dual acting histone deacetylases (HDACs) and phosphodiesterase 5 (PDE5) inhibitors for the treatment of Alzheimer's disease","volume":"59","author":"Rabal","year":"2016","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.neuropharm.2017.08.017_bib43","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.tips.2008.12.004","article-title":"The enigmatic pharmacology of GPR55","volume":"30","author":"Ross","year":"2009","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2017.08.017_bib44","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1007\/s11064-005-6978-1","article-title":"Agonistic properties of cannabidiol at 5-HT1a receptors","volume":"30","author":"Russo","year":"2005","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neuropharm.2017.08.017_bib45","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1038\/sj.bjp.0707460","article-title":"The orphan receptor GPR55 is a novel cannabinoid receptor","volume":"152","author":"Ryberg","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.08.017_bib46","first-page":"6b00370","article-title":"Impact of scaffold exploration on novel dual-acting histone deacetylases and phosphodiesterase 5 inhibitors for the treatment of Alzheimer's disease","author":"S\u00e1nchez-Arias","year":"2016","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.neuropharm.2017.08.017_bib47","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0169-328X(98)00277-0","article-title":"Identification and cloning of three novel human G protein-coupled receptor genes GPR52, \u03a8GPR53 and GPR55: GPR55 is extensively expressed in human brain","volume":"64","author":"Sawzdargo","year":"1999","journal-title":"Mol. Brain Res."},{"key":"10.1016\/j.neuropharm.2017.08.017_bib48","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1002\/ibd.21538","article-title":"The atypical cannabinoid O-1602 protects against experimental colitis and inhibits neutrophil recruitment","volume":"17","author":"Schicho","year":"2011","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.neuropharm.2017.08.017_bib49","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s00441-004-0938-y","article-title":"Classic toxin-induced animal models of Parkinson's disease: 6-OHDA and MPTP","volume":"318","author":"Schober","year":"2004","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.neuropharm.2017.08.017_bib50","doi-asserted-by":"crossref","first-page":"8104","DOI":"10.1021\/jm100971t","article-title":"In\u00a0vivo characterization of a dual adenosine A2A\/A1 receptor antagonist in animal models of Parkinson's disease","volume":"53","author":"Shook","year":"2010","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.neuropharm.2017.08.017_bib51","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.pain.2008.04.006","article-title":"The putative cannabinoid receptor GPR55 plays a role in mechanical hyperalgesia associated with inflammatory and neuropathic pain","volume":"139","author":"Staton","year":"2008","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2017.08.017_bib52","doi-asserted-by":"crossref","first-page":"4029","DOI":"10.1167\/iovs.14-14879","article-title":"Role of endothelium in abnormal cannabidiol-induced vasoactivity in retinal arterioles","volume":"56","author":"Su","year":"2015","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.neuropharm.2017.08.017_bib53","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.lfs.2013.09.011","article-title":"Moving around the molecule: relationship between chemical structure and in\u00a0vivo activity of synthetic cannabinoids","volume":"97","author":"Wiley","year":"2014","journal-title":"Life Sci."},{"key":"10.1016\/j.neuropharm.2017.08.017_bib54","doi-asserted-by":"crossref","first-page":"e60314","DOI":"10.1371\/journal.pone.0060314","article-title":"GPR55, a G-protein coupled receptor for lysophosphatidylinositol, plays a role in motor coordination","volume":"8","author":"Wu","year":"2013","journal-title":"PLoS One"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390817303842?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390817303842?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T22:28:01Z","timestamp":1750804081000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390817303842"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":54,"alternative-id":["S0028390817303842"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2017.08.017","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"GPR55: A therapeutic target for Parkinson's disease?","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2017.08.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}